Clinical Trial Update: Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. [Phase 3]

View source ↗

Summary

A Phase 3 immunization and safety study comparing two formulations of DTPw-HBV/HIB given at birth with Hepatitis B at 2, 4, and 6 months was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTPw-HBV/Hib vaccine (Diphtheria and Tetanus Toxoids and Whole-Cell Pertussis vaccine, with Hepatitis B and Haemophilus influenzae type b)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Diphtheria | Phase 3 | Status: TERMINATED